Protagonist Therapeutics (PTGX) had the lowest return in April 2022 by a mid-cap US stock or mid-cap US stock, returning -61.9%.
Protagonist Therapeutics (PTGX) had the lowest return in April 2022 by a mid-cap US stock or mid-cap US stock, returning -61.9%.
Mid-cap stocks are treated as having a market cap between $2B and $10B.